Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

James Altunkaya

James Altunkaya

James Altunkaya

NIHR Doctoral Research Fellow

James is a NIHR Doctoral Research Fellow in the Health Economics Research Centre (HERC) at Oxford Population Health. He aims to provide economic evidence regarding the role of precision medicine in prediabetes. 

For his DPhil, he is building and validating a new economic model of prediabetes and its consequences. This combines data from several clinical trials and cohort studies to predict individual patients’ long-term health outcomes and costs. This will allow s to understand the cost-effectiveness of early precision interventions targeted to specific prediabetes patients. 

He has joined HERC in 2019 as a researcher in health economics, and prior to this held a NIHR Research Methods Fellowship at the Centre for Health Economics at the University of York. There, he was a member of the NICE academic evidence review group, critiquing the economic case for introducing new pharmaceuticals and medical devices into the NHS. 

He holds a MSc in Public Health (Health Economics) from the London School of Hygiene and Tropical Medicine, and a BA in Philosophy, Politics and Economics from the University of Oxford.